Clinton HIV/AIDS Year-End Report Release

CLINTON HIV/AIDS INITIATIVE YEAR-END REPORT

Helping 1.4 million people access more affordable lifesaving HIV/AIDS treatment. Clinton HIV/AIDS Initiative (CHAI) makes significant gains in the fight against HIV/AIDS and malaria "...I love the Clinton Foundation... It's because they have what every organization in the field should have - [the belief] that every minute you lose, you lose another life. If it hadn't been for the Clinton Foundation's negotiation around the generic drugs I don't know how many more hundreds of thousands of people would have died unnecessarily." - Stephen Lewis, Former UN Special Envoy for HIV/AIDS in Africa, speaking on World AIDS Day 2008. Under the leadership of President Clinton and at the invitation of national governments, CHAI works to expand access to high-quality HIV/AIDS care and treatment by improving the efficiency of the commodity marketplace and by supporting governments to develop robust national HIV/AIDS programs. Over the past six years, CHAI has mobilized technical and business expertise to help governments make better use of available resources to save more lives. An estimated 33 million people around the world are living with HIV/AIDS, and in the developing world, an estimated 10 million of them are in immediate need of treatment. At the end of 2007, only 3 million people were receiving antiretroviral (ARV) therapy. CHAI's innovative efforts to reach those in need continue to make significant steps toward closing the gap. CHAI'S WORK TO DATE President Clinton launched the Clinton HIV/AIDS Initiative in 2002. To date: · 1.4 million people are benefiting from medicines purchased under CHAI agreements, as of the beginning of 2008 · More than 70 countries have access to CHAI prices for drugs and diagnostics - representing more than 90% of people living with HIV globally · 22 countries receive on-the-ground technical assistance to design policies and practices that enable governments to practically and affordably strengthen their basic health systems and expand access to HIV/AIDS care and treatment · Since 2005, CHAI has negotiated an overall 90% price reduction of pediatric medicines, lowering the price from $600 to $60 per child, per year · Through a partnership with UNITAID, CHAI is reaching 300,000 people in 37 countries with $100 million worth of medicines, diagnostics, and therapeutic food · CHAI completed pricing agreements with more than 10 ARV and ACT suppliers covering more than 40 formulations. In the past two years alone, CHAI achieved cumulative price reductions in low-income countries of 60 percent for pediatric ARVs and of 30 percent for second-line ARVs · CHAI negotiated price reductions with 12 manufacturers for 16 HIV/AIDS diagnostic and monitoring tests. These negotiations have resulted in price reductions of up to 80 percent for some products and has allowed for the introduction of crucial tests otherwise not available in many of the countries in which we work 2008 CHAI ACCOMPLISHMENTS In 2008, CHAI has: · Negotiated, in partnership with UNITAID, a deal to lower the price of pediatric and second-line medicines by more than 20 percent from previous levels · Finalized agreements to increase access to effective malaria medicines, called ACTs. CHAI improved global demand forecasts and conducted negotiations with six suppliers, effectively lowering the price of one of the most common ACT combinations by more than 30 percent and reducing the price volatility of the main ingredient in ACT by 70 percent. In addition, CHAI is mobilizing technical assistance to support the first countries that are implementing a global ACT subsidy · Increased access to testing for children as part of an effort to reach tens of thousands of children with high-quality treatment. This included broadening the scope of CHAI's agreement with the market leader of CD4 testing instruments in the developing world to include the measurement of CD4% - used to stage and monitor HIV-positive children - at a significant price reduction. CHAI also increased the number of sites offering HIV diagnosis testing for infants from 1,400 to 2,500 worldwide · Responded to the continued increase of mother-to-child transmission of HIV by initiating programs to dramatically reduce transmission in seven countries. CHAI is working with partner governments to ensure that a full cascade of prevention of mother-to-child transmission (PMTCT) services is provided to all HIV-positive pregnant women and their children within targeted regions. Lessons learned from this process will inform national scale-up and international PMTCT policy * Increased the capacity of health care workers by deploying approximately 60 mentors to more than 100 sites across a dozen countries. CHAI also developed management training programs with the Ministries of Health of two countries; implemented community health care worker and expert patient programs across a number of countries; and improved the efficiency of pre-service training in two countries, which doubled the number of lab assistants in one country in a single year * Worked with eight governments to develop cost-effective models to expand HIV/AIDS and health services to remote and chronically underserved areas. In Rwanda, CHAI and the Ministry of Health worked together to develop detailed plans and to raise resources for the scale-up of comprehensive health care for all 27 districts outside Kigali